mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |